tiprankstipranks
Medexus Pharmaceuticals Inc (DE:P731)
FRANKFURT:P731
Germany Market
P731
Medexus Pharmaceuticals Inc
RESEARCH TOOLSreports

Medexus Pharmaceuticals Inc (P731) Financial Statements

2 Followers

Medexus Pharmaceuticals Inc Financial Overview

Medexus Pharmaceuticals Inc's market cap is currently €78.57M. The company's EPS TTM is €-0.0075; its P/E ratio is -334.24; Medexus Pharmaceuticals Inc is scheduled to report earnings on February 11, 2026, and the estimated EPS forecast is €>-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total RevenueC$ 108.33MC$ 108.10MC$ 76.70MC$ 79.66MC$ 74.36M
Gross ProfitC$ 56.58MC$ 60.04MC$ 37.93MC$ 42.01MC$ 29.44M
Operating IncomeC$ 8.22MC$ 7.61MC$ -12.38MC$ -1.38MC$ -1.48M
EBITDAC$ 16.81MC$ 14.65MC$ 14.55MC$ -23.61MC$ 3.78M
Net IncomeC$ 2.25MC$ 1.22MC$ -2.88MC$ -28.26MC$ -4.70M
Balance Sheet
Cash & Short-Term InvestmentsC$ 23.97MC$ 13.07MC$ 10.02MC$ 18.70MC$ 5.23M
Total AssetsC$ 171.84MC$ 161.33MC$ 139.22MC$ 148.51MC$ 122.81M
Total DebtC$ 37.18MC$ 70.08MC$ 54.86MC$ 44.87MC$ 38.81M
Net DebtC$ 13.21MC$ 77.06MC$ 44.84MC$ 26.17MC$ 33.58M
Total LiabilitiesC$ 119.69MC$ 138.88MC$ 121.43MC$ 130.50MC$ 98.53M
Stockholders' EquityC$ 52.14MC$ 22.45MC$ 17.79MC$ 18.02MC$ 24.28M
Cash Flow
Free Cash FlowC$ 21.31MC$ -1.81MC$ -8.89MC$ -5.72MC$ -3.54M
Operating Cash FlowC$ 24.03MC$ -1.44MC$ -1.18MC$ 5.04MC$ -3.43M
Investing Cash FlowC$ -6.00MC$ -1.72MC$ -8.20MC$ -11.70MC$ -30.32M
Financing Cash FlowC$ 796.00KC$ 6.41MC$ 663.00KC$ 18.68MC$ 15.42M
Currency in CAD

Medexus Pharmaceuticals Inc Earnings and Revenue History

Income Statement >

Medexus Pharmaceuticals Inc Debt to Assets

Balance Sheet >

Medexus Pharmaceuticals Inc Cash Flow

Cash Flow >

Medexus Pharmaceuticals Inc Forecast EPS vs Actual EPS

Earnings >